GlassScriptPhysician profile
Kendra W Marcinowski
NPI 1447633375
$1,419.14
in general payments reported to CMS, 2019-2025
19 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $275 · 2022: $296 · 2023: $338 · 2024: $258 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $289.22 | 2021-2025 | |
| Astellas Pharma US INC | $236.82 | 2023-2025 | Veozah |
| Abbvie INC. | $208.62 | 2021-2023 | |
| Hologic Sales and Service, LLC | $187.06 | 2021-2025 | Aptima, Acessa Provu System |
| Sumitomo Pharma America, INC. | $62.83 | 2023-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $59.75 | 2021 | |
| Exeltis, USA INC. | $53.82 | 2021-2023 | Slynd |
| Therapeuticsmd, INC. | $48.09 | 2021-2022 | |
| Daiichi Sankyo INC. | $44.00 | 2021-2022 | |
| Pfizer INC. | $35.34 | 2023-2024 | |
| Millicent US INC | $32.42 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Avion Pharmaceuticals | $30.75 | 2022-2023 | Balcoltra |
| Teleflex LLC | $24.76 | 2025 | Quikclot |
| Pacira Pharmaceuticals Incorporated | $21.61 | 2023 | Exparel |
| Sage Therapeutics, LLC | $20.61 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.12 | 2024 | Evenity, Prolia |
| Agile Therapeutics, INC. | $15.86 | 2022 | |
| Medicem INC. | $14.26 | 2021 | |
| Myovant Sciences INC. | $14.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Marcinowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.